Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

84.33 -0.57 (-0.67%)
Streaming Delayed Price Updated: 11:39 AM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
55 56 Next >
News headline image
Nearing Retirement? These Stocks Are as Cautious as They Come ↗
Healthcare blue chips can provide retirees the consistency they need while growing their nest eggs further. 
Via The Motley Fool
News headline image
3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade ↗
These stocks don't offer the highest yields, but their payouts are growing fast. 
Via The Motley Fool
News headline image
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio ↗
Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare. 
Via InvestorPlace
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Could Abbott Laboratories Stock Help You Become a Millionaire? ↗
Abbott's earnings have soared over the past decade. 
Via The Motley Fool
Abbott Laboratories (NYSE: ABT) Records 52-Week High Friday Morning
Via Investor Brand Network
News headline image
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Peering Into Abbott Laboratories's Recent Short Interest ↗
 
Via Benzinga
News headline image
This Is What Whales Are Betting On Abbott Laboratories ↗
 
Via Benzinga
News headline image
Looking for Growth? 7 Hot Trends That Have Been Flying Under Investors’ Radar. ↗
Discover 7 under-the-radar stock trends set to make waves in the stock market. Find out why savvy investors are tuning in. 
Via InvestorPlace
News headline image
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth ↗
Explore recession-proof stocks thriving in Energy, Health Care, Industrials, and more, offering stability and growth amid economic turmoil. 
Via InvestorPlace
News headline image
Abbott Laboratories Stock Gets A Healthy Technical Rating Upgrade ↗
In a welcome move, Abbott Laboratories stock saw its Relative Strength Rating improve from 67 to 73 on Wednesday. 
Via Investor's Business Daily
News headline image
3 Cash Cows to Boost Your Confidence During the February Chill ↗
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns. 
Via InvestorPlace
News headline image
The Smartest Dividend Stocks to Buy With $400 Right Now ↗
These stocks reward you during any market environment. 
Via The Motley Fool
News headline image
Is Abbott Laboratories Stock a Buy Now? ↗
Can Abbott Laboratories be a reliable income stock to hang on to now? 
Via The Motley Fool
News headline image
Looking At Abbott Laboratories's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device ↗
FDA panel confirms support (13-1) for Abbott Laboratories' TriClip TEER system in treating tricuspid regurgitation. Approval decision expected from FDA in 2024. 
Via Benzinga
News headline image
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom ↗
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document. 
Via Benzinga
News headline image
Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How. ↗
Abbott Labs has an impressive portfolio of nutrition drinks, and its latest addition could help it profit from a new market: people taking prescribed weight loss drugs. 
Via The Motley Fool
News headline image
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains ↗
Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector. 
Via InvestorPlace
News headline image
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys? ↗
There's room for multiple winners in the fast-growing weight-loss market. 
Via The Motley Fool
News headline image
Abbott Laboratories Stock Getting Closer To Key Technical Benchmark ↗
Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
News headline image
7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates ↗
When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time. 
Via InvestorPlace
News headline image
Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever ↗
Healthcare is an excellent place to find some tried and true wealth compounders. 
Via The Motley Fool
News headline image
Healthcare And Life Science Funds And ETFs Performance 2023-2024 ↗
Healthcare stocks usually provide a defensive posture to a stock portfolio. 
Via Talk Markets
Topics ETFs
News headline image
2 Stocks to Buy Near Their 52-Week Highs ↗
It's not too late to invest in these stocks. 
Via The Motley Fool
News headline image
2 Healthcare Dividend Kings to Buy and Hold Forever ↗
It's going to take a lot to interrupt these companies' streaks. 
Via The Motley Fool
News headline image
Abbott Faces Lawsuit As Grandmother Questions PediaSure's Height Growth Claims ↗
Abbott Laboratories faces a lawsuit questioning the efficacy of PediaSure Grow & Gain nutrition drinks in promoting height growth. 
Via Benzinga
Topics Lawsuit
News headline image
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market? ↗
Abbott Labs is using its well-established strengths to make gains in the weight loss market. 
Via The Motley Fool
News headline image
4 med tech stocks with improving prognosis for 2024
MedTech stocks have had plenty of reason to rally over the last year but haven't. That is about to change with growth accelerating in 2024 and 2025. 
Via MarketBeat
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
55 56 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.